Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 06 Apr 2026 for Keros Therapeutics, Inc., €14k.
Filing timeline
BuySaleJasbir Seehra
Insider track record
Disclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jasbir Seehra: trading record in brief
Jasbir Seehra discloses dealings in Keros Therapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 13 April 2020 to 2 April 2026, the count stands at 8 filings.
In open-market terms, that means 1 purchase worth €293k on one side and 1 sale worth €96k on the other. Netting one side against the other leaves €197k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 1 share grant and 4 option exercises. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 6 April 2026, reports an option exercise of €14k in Keros Therapeutics, Inc. The clock since the last published purchase (13 April 2020) now reads 2,384 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jasbir Seehra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
55,000 shares@ US$0.3046.3% of flowCommon StockSEC:0001732369-26-000010:0
7,015 shares@ US$16.1775.7% of flowCommon StockSEC:0001732369-26-000004:0
90,500 shares0Common StockSEC:0001415889-25-023791:0
49,367 shares@ US$0.3080.9% of flowCommon StockSEC:0001415889-25-010290:0
4,000 shares@ US$0.4810.6% of flowCommon StockSEC:0001209191-23-023991:0
5,000 shares@ US$0.301.1% of flowCommon StockSEC:0001209191-22-035848:0
6 of 6 declarations
